<DOC>
	<DOCNO>NCT01461213</DOCNO>
	<brief_summary>- Primary objective : To assess safety tolerability AAV.REP1 vector , administer two different dos retina 12 patient diagnosis choroideremia . - Secondary Objective : To identify therapeutic benefit evidence slow retinal degeneration assess functional anatomical method treat eye compare control eye 24 month gene delivery .</brief_summary>
	<brief_title>Gene Therapy Blindness Caused Choroideremia</brief_title>
	<detailed_description>Detailed description may find follow scientific publication : Retinal gene therapy patient choroideremia : initial finding phase 1/2 clinical trial , The Lancet , Volume 383 , Issue 9923 , Pages 1129 - 1137 ( 29 March 2014 ) . Links : www.thelancet.com/journals/lancet/article/PIIS0140-6736 ( 13 ) 62117-0/abstract ; http : //dx.doi.org/doi:10.1016/S0140-6736 ( 13 ) 62117-0</detailed_description>
	<mesh_term>Choroideremia</mesh_term>
	<criteria>Participant willing able give inform consent participation study , Male age 18 year , Diagnosed choroideraemia good health , Active disease SLO change visible within macula region , Willing allow General Practitioner consultant , appropriate , notified participation study , Vision least 6/60 good study eye . Female child participant ( age 18 ) , Men unwilling use barrier contraception method , relevant , Previous history retinal surgery ocular inflammatory disease ( uveitis ) , Grossly asymmetrical disease ocular morbidity might confound use fellow eye longterm control , Any significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study , Participants participate another research study involve investigational product previous 12 week .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Tapetoretinal degeneration , choroideraemia , X-linked</keyword>
	<keyword>retinitis pigmentosa</keyword>
</DOC>